{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:15:53Z","timestamp":1791270953868,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T00:00:00Z","timestamp":1132012800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s00415-005-0887-8","type":"journal-article","created":{"date-parts":[[2005,11,11]],"date-time":"2005-11-11T20:38:31Z","timestamp":1131741511000},"page":"1459-1464","source":"Crossref","is-referenced-by-count":31,"title":["Paclitaxel plus carboplatin\u2013induced peripheral neuropathy"],"prefix":"10.1007","volume":"252","author":[{"given":"A. A.","family":"Argyriou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Polychronopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Iconomou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Koutras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. P.","family":"Kalofonos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Chroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,11,15]]},"reference":[{"key":"887_CR1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/01.WNL.0000148609.35718.7D","volume":"64","author":"Argyriou","year":"2005","unstructured":"Argyriou AA, Chroni E, Koutras A, et al. (2005) Vitamin E for prophylaxis against chemotherapy\u2013induced neuropathy: a randomized controlled trial. Neurology 64(1):26\u201331","journal-title":"Neurology"},{"key":"887_CR2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00520-005-0776-9","volume":"13","author":"Argyriou","year":"2005","unstructured":"Argyriou AA, Polychronopoulos P, Koutras A, et al. (2005) Peripheral neuropathy induced by administration of cisplatin and paclitaxel\u2013based chemotherapy. Could it be predicted? Support Care Cancer 13(8):647\u2013651","journal-title":"Support Care Cancer"},{"key":"887_CR3","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0959-8049(97)00103-2","volume":"33","author":"Berger","year":"1997","unstructured":"Berger T, Malayeri R, Doppelbauer G, et al. (1997) Neurological monitoring of neurotoxicity induced by paclitaxel\/ cisplatin chemotherapy. Eur J Cancer 33(9):1393\u20131399","journal-title":"Eur J Cancer"},{"key":"887_CR4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.410350310","volume":"35","author":"Chaudhry","year":"1994","unstructured":"Chaudhry V, Rowinsky EK, Sartorius SE, et al. (1994) Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies. Ann Neurol 35:304\u2013311","journal-title":"Ann Neurol"},{"key":"887_CR5","first-page":"6","volume":"23","author":"Davidson","year":"1996","unstructured":"Davidson NG (1996) Single\u2013agent paclitaxel as first\u2013line treatment of metastatic breast cancer: the British experience. Semin Oncol 23(suppl 11):6\u201310","journal-title":"Semin Oncol"},{"key":"887_CR6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/scientificamerican0880-66","volume":"243","author":"Dustin","year":"1980","unstructured":"Dustin P (1980) Microtubules. Sci Am 243:66\u201376","journal-title":"Sci Am"},{"key":"887_CR7","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/djg036","volume":"95","author":"du Bois","year":"2003","unstructured":"du Bois A, Luck HJ, Meier W, et al. (2003) Arbeitsgemeinschaft Gynakologische Onkologie Ovarian Cancer Study Group. A randomized clinical trial of cisplatin\/paclitaxel versus carboplatin\/ paclitaxel as first\u2013line treatment of ovarian cancer. J Natl Cancer Inst 95(17):1320\u20131329","journal-title":"J Natl Cancer Inst"},{"key":"887_CR8","unstructured":"Dyck PJ, Thomas PK (1993) (eds): Peripheral Neuropathy (ed 3). Vol 2. Philadelphia, PA, WB Saunders, pp 1310\u20131317"},{"key":"887_CR9","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/annonc\/mdh395","volume":"15","author":"Fountzilas","year":"2004","unstructured":"Fountzilas G, Kalofonos HP, Dafni U, et al. (2004) Paclitaxel and epirubicin versus paclitaxel and carboplatin as first\u2013line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group. Ann Oncol 15(10):1517\u20131526","journal-title":"Ann Oncol"},{"key":"887_CR10","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.1998.16.7.2426","volume":"16","author":"Gore","year":"1998","unstructured":"Gore M, Mainwaring P, A\u2019Hern R, et al. (1998) Randomized trial of dose\u2013intensity with single\u2013agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group. J Clin Oncol 16(7):2426\u20132434","journal-title":"J Clin Oncol"},{"key":"887_CR11","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1200\/JCO.1997.15.5.1953","volume":"15","author":"Huizing","year":"1997","unstructured":"Huizing MT, van Warmerdam LJ, Rosing H, et al. (1997) Phase I and pharmacologic study of the combination paclitaxel and carboplatin as first\u2013line chemotherapy in stage III and IV ovarian cancer. J Clin Oncol 15(5):1953\u20131964","journal-title":"J Clin Oncol"},{"key":"887_CR12","unstructured":"Kimura J (2001) Electrodiagnosis in diseases of nerve and muscle, principles and practice (ed 3). Oxford University press, pp 91\u2013166"},{"key":"887_CR13","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","volume":"14","author":"Kleyweg","year":"1991","unstructured":"Kleyweg RP, Van der Mech\u00e9 FGA, Schmitz PIM (1991) Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain\u2013Barr\u00e9 syndrome. Muscle Nerve 14:1103\u20131109","journal-title":"Muscle Nerve"},{"key":"887_CR14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/annonc\/mdi009","volume":"16","author":"Lilenbaum","year":"2005","unstructured":"Lilenbaum RC, Chen CS, Chidiac T, et al. (2005) Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non\u2013small\u2013cell lung cancer. Ann Oncol 16(1):97\u2013101","journal-title":"Ann Oncol"},{"key":"887_CR15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s004320000157","volume":"127","author":"Markman","year":"2001","unstructured":"Markman M, Kennedy A, Webster K, et al. (2001) Neurotoxicity associated with a regimen of carboplatin (AUC 5\u20136) and paclitaxel (175 mg\/m2 over 3 h) employed in the treatment of gynecologic malignancies. J Cancer Res Clin Oncol 127(1):55\u201358","journal-title":"J Cancer Res Clin Oncol"},{"key":"887_CR16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1023\/A:1008211203563","volume":"8","author":"McGuire","year":"1997","unstructured":"McGuire WP (1997) How many more nails to seal the coffin of dose intensity? Ann Oncol 8(4):311\u2013313","journal-title":"Ann Oncol"},{"key":"887_CR17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207\u2013214","journal-title":"Cancer"},{"key":"887_CR18","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","volume":"21","author":"Ozols","year":"2003","unstructured":"Ozols RF, Bundy BN, Greer BE, et al. (2003) Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 21(17):3194\u20133200","journal-title":"J Clin Oncol"},{"key":"887_CR19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0924-980X(96)95635-0","volume":"101","author":"Panayiotopoulos","year":"1996","unstructured":"Panayiotopoulos CP, Chroni E (1996) F\u2013waves in clinical neurophysiology: a review. Methodological issues and overall value in peripheral neuropathies. Electroencephalogr Clin Neurophysiol 101:365\u2013374","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"887_CR20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00019052-200210000-00015","volume":"15","author":"Peltier","year":"2002","unstructured":"Peltier AC, Russell JW (2002) Recent advances in drug\u2013induced neuropathies. Curr Opin Neurol 15(5):633\u2013638","journal-title":"Curr Opin Neurol"},{"key":"887_CR21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/PL00007853","volume":"249","author":"Quasthoff","year":"2002","unstructured":"Quasthoff S, Hartung HP (2002) Chemotherapy\u2013induced peripheral neuropathy. J Neurol 249(1):9\u201317","journal-title":"J Neurol"},{"key":"887_CR22","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/jnci\/82.15.1247","volume":"82","author":"Rowinsky","year":"1990","unstructured":"Rowinsky EK, Cazenave LA, Donehower RC (1990) Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst 82:1247\u20131259","journal-title":"J Natl Cancer Inst"},{"key":"887_CR23","first-page":"1","volume":"20","author":"Rowinsky","year":"1993","unstructured":"Rowinsky EK, Eisenhauer EA, Chaudhry V, et al. (1993) Clinical toxicities encountered by paclitaxel (Taxol). Semin Oncol 20:1\u201315","journal-title":"Semin Oncol"},{"key":"887_CR24","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","volume":"332","author":"Rowinsky","year":"1995","unstructured":"Rowinsky EK, Donehower RC (1995) Paclitaxel (Taxol). NEJM 332:1004\u20131014","journal-title":"NEJM"},{"key":"887_CR25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1212\/WNL.29.4.429","volume":"29","author":"Schaumburg","year":"1979","unstructured":"Schaumburg HH, Spencer PS (1979) Toxic neuropathies. Neurology 29:429\u2013431","journal-title":"Neurology"},{"key":"887_CR26","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1200\/JCO.1997.15.4.1291","volume":"15","author":"Thigpen","year":"1997","unstructured":"Thigpen JT (1997) Dose\u2013intensity in ovarian carcinoma: hold, enough? J Clin Oncol 15(4):1291\u20131293","journal-title":"J Clin Oncol"},{"key":"887_CR27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00019052-199910000-00010","volume":"12","author":"Windebank","year":"1999","unstructured":"Windebank AJ (1999) Chemotherapeutic neuropathy. Curr Opin Neurol 12:565\u2013571","journal-title":"Curr Opin Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-005-0887-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-005-0887-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-005-0887-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:04:02Z","timestamp":1559070242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-005-0887-8"}},"subtitle":["A prospective clinical and electrophysiological study in patients suffering from solid malignancies"],"short-title":[],"issued":{"date-parts":[[2005,11,15]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["887"],"URL":"https:\/\/doi.org\/10.1007\/s00415-005-0887-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,15]]}}}